Compare ANTX & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANTX | SRBK |
|---|---|---|
| Founded | 2017 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 149.8M |
| IPO Year | 2022 | 2023 |
| Metric | ANTX | SRBK |
|---|---|---|
| Price | $4.92 | $19.09 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 353.1K | 31.0K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | 32.56 | ★ 138.36 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $61.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $13.55 |
| 52 Week High | $6.91 | $20.20 |
| Indicator | ANTX | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 51.24 |
| Support Level | $3.91 | $18.74 |
| Resistance Level | $5.13 | $19.61 |
| Average True Range (ATR) | 0.36 | 0.45 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 80.00 | 40.63 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.